ModerateCardiovascularHeart failure with reduced ejection fractionuk-plab-1
A 68-year-old man with long-standing hypertension and type 2 diabetes is newly diagnosed with heart failure with reduced ejection fraction on echocardiogram (LVEF 30%). He is breathless on minimal exertion. Which drug combination is most appropriate as the foundation of his disease-modifying therapy?